FDA Adverse Event Malfunction Summary report: N

BD MACRO-VUE¿ RPR CARD ANTIGEN SUSPENSION

MDR report key: 12375250 · Received August 26, 2021

Report

Report Number
2647876-2021-00054
Event Type
Malfunction
Date Received
August 26, 2021
Date of Event
July 28, 2021
Report Date
November 18, 2021
Manufacturer
BECTON DICKINSON CARIBE LTD.
Product Code
GMQ
UDI-DI
30382902703090
PMA / PMN Number
PREAMENDMENT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS MDR SHOULD BE CONSIDERED CANCELLED. IN THIS PARTICULAR EVENT, THE DIAGNOSTIC TEST IS PERFORMED WITH THE UNDERSTANDING AND RECOMMENDATION TO PERFORM CONCURRENT CONTROLS TO ASSURE ACCURACY. THEREFORE, ERRONEOUS RESULTS WOULD BE SUSPECTED AND LEAD TO RETESTING. THIS WILL NOT LIKELY LEAD TO A SERIOUS ADVERSE EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING BD MACRO-VUE¿ RPR CARD ANTIGEN SUSPENSION ATYPICAL GROWTH WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: " IT WAS REPORTED THAT THERE WAS LOWER REACTIVITY WITH THE NEW RPR LOT# 1123493. ".

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT WHILE USING BD MACRO-VUE¿ RPR CARD ANTIGEN SUSPENSION ATYPICAL GROWTH WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED THAT THERE WAS LOWER REACTIVITY WITH THE NEW RPR LOT# 1123493.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1273111 BD MACRO-VUE¿ RPR CARD ANTIGEN SUSPENSION ANTIGENS, NONTREPONEMAL, ALL GMQ BECTON DICKINSON CARIBE LTD. 270309 1123493 30382902703090

Patients

Seq Age Sex Outcome Treatment
1 Unknown